XML 22 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Jul. 31, 2024
Jul. 31, 2023
Cash flows from operating activities:    
Net loss $ (4,453,000) $ (7,039,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation of fixed assets 204,000 71,000
Amortization of intangible assets 33,000 40,000
Amortization of right of use assets 207,000 135,000
(Accretion of discount)/amortization of premium on investments (106,000)
Change in contingent consideration liability (62,000)
Stock based compensation 259,000 401,000
Changes in operating assets and liabilities:    
Accounts receivable (167,000) 15,000
Contract assets (459,000) (141,000)
Inventory (850,000) (686,000)
Other assets 962,000 375,000
Accounts payable (1,625,000) 345,000
Earnout payable (50,000) (500,000)
Accrued expenses (208,000) (540,000)
Right-of-use liabilities (121,000) (127,000)
Contract liabilities 144,000 (171,000)
Net cash used in operating activities (6,124,000) (7,990,000)
Cash flows from investing activities:    
Redemptions of short-term investments 11,718,000
Purchases of short-term investments (6,612,000)
Purchases of property and equipment (374,000) (133,000)
Net cash (used in)/provided by investing activities (374,000) 4,973,000
Cash flows from financing activities:    
Cash paid for tax withholding related to shares withheld (2,000)
Proceeds from issuance of common stock - At The Market offering, net of issuance costs 6,529,000
Net cash provided by/(used in) financing activities 6,529,000 (2,000)
Net increase/(decrease) in cash, cash equivalents and restricted cash 31,000 (3,019,000)
Cash, cash equivalents and restricted cash, beginning of period 3,305,000 7,103,000
Cash, cash equivalents and restricted cash, end of period 3,336,000 4,084,000
Supplemental disclosure of noncash investing and financing activities:    
Common stock issued related to bonus and earnout payments $ 630,000 $ 1,250,000